These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 9468039)

  • 1. Phase II trial of merbarone in patients with malignant brain tumors.
    Malik UR; Dutcher JP; Caliendo G; Lasala P; Mitnick R; Wiernik PH
    Med Oncol; 1997; 14(3-4):159-62. PubMed ID: 9468039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical and pharmacological study of merbarone.
    Dimaggio JJ; Warrell RP; Muindi J; Stevens YW; Lee SJ; Lowenthal DA; Haines I; Walsh TD; Baltzer L; Yaldaei S
    Cancer Res; 1990 Feb; 50(4):1151-5. PubMed ID: 2297763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
    Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
    J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.
    Slavik M; Liu PY; Kraut EH; Natale RB; Flaherty LE; Sondak VK
    Invest New Drugs; 1995; 13(2):143-7. PubMed ID: 8617577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of merbarone in patients with adenocarcinoma of the pancreas.
    Jones DV; Ajani JA; Winn RJ; Daugherty KR; Levin B; Krakoff IH
    Cancer Invest; 1993; 11(6):667-9. PubMed ID: 8221199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group study.
    Kraut EH; Bendetti J; Balcerzak SP; Doroshow JH
    Invest New Drugs; 1992 Nov; 10(4):347-9. PubMed ID: 1487411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study.
    Kraut EH; Fleming T; Macdonald JS; Spiridonidis CH; Bradof JE; Baker LH
    Am J Clin Oncol; 1993 Aug; 16(4):327-8. PubMed ID: 8328410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
    Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
    Ann Oncol; 1996 Feb; 7(2):205-7. PubMed ID: 8777179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoma/merbarone. A Southwest Oncology Group study.
    Poplin EA; Tangen CM; Harvey WH; Macdonald JS
    Invest New Drugs; 1994; 12(4):337-40. PubMed ID: 7775137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma.
    Ajani JA; Winn R; Baez L; Pollock T; Maher T; Hallinan-Fueger B; Newman J
    Cancer Invest; 1994; 12(5):488-90. PubMed ID: 7922705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
    J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
    Pipas JM; Meyer LP; Rhodes CH; Cromwell LD; McDonnell CE; Kingman LS; Rigas JR; Fadul CE
    J Neurooncol; 2005 Feb; 71(3):301-5. PubMed ID: 15735921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merbarone: an antitumor agent entering clinical trials.
    Glover A; Chun HG; Kleinman LM; Cooney DA; Plowman J; Grieshaber CK; Malspeis L; Leyland-Jones B
    Invest New Drugs; 1987; 5(2):137-43. PubMed ID: 3308762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy.
    Grossman SA; Hochberg F; Fisher J; Chen TL; Kim L; Gregory R; Grochow LB; Piantadosi S
    Cancer Chemother Pharmacol; 1998; 42(2):118-26. PubMed ID: 9654111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.
    Reardon DA; Quinn JA; Rich JN; Gururangan S; Vredenburgh J; Sampson JH; Provenzale JM; Walker A; Badruddoja M; Tourt-Uhlig S; Herndon JE; Dowell JM; Affronti ML; Jackson S; Allen D; Ziegler K; Silverman S; Bohlin C; Friedman AH; Bigner DD; Friedman HS
    Neuro Oncol; 2004 Apr; 6(2):134-44. PubMed ID: 15134628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of merbarone in renal cell carcinoma.
    Flanigan RC; Saiers JH; Wolf M; Kraut EH; Smith AY; Blumenstein B; Crawford ED
    Invest New Drugs; 1994; 12(2):147-9. PubMed ID: 7860233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    Look KY; Blessing JA; Adelson MD; Morris M; Bookman MA
    Am J Clin Oncol; 1996 Feb; 19(1):7-9. PubMed ID: 8554040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.